195 related articles for article (PubMed ID: 25394467)
1. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.
Wang CW; Yang SP; Hu H; Du J; Li FH
Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and in vitro evaluation of targeted gold nanoshelled poly(d,l-lactide-co-glycolide) nanoparticles carrying anti p53 antibody as a theranostic agent for ultrasound contrast imaging and photothermal therapy.
Xu L; Wan C; Du J; Li H; Liu X; Yang H; Li F
J Biomater Sci Polym Ed; 2017 Mar; 28(4):415-430. PubMed ID: 28044473
[TBL] [Abstract][Full Text] [Related]
3. Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study.
Li XY; Xu L; Li HL; Du J; Liu XS; Li FH
Mol Med Rep; 2018 Mar; 17(3):3763-3768. PubMed ID: 29286171
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of poly(D,L-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging.
Néstor MM; Kei NP; Guadalupe NA; Elisa ME; Adriana GQ; David QG
Ultrasonics; 2011 Oct; 51(7):839-45. PubMed ID: 21570702
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
6. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
7. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents.
Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258
[TBL] [Abstract][Full Text] [Related]
8. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
9. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
10. Design of PLGA based nanoparticles for imaging guided applications.
Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
[TBL] [Abstract][Full Text] [Related]
11. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
12. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound degradation of novel polymer contrast agents.
El-Sherif DM; Lathia JD; Le NT; Wheatley MA
J Biomed Mater Res A; 2004 Jan; 68(1):71-8. PubMed ID: 14661251
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Imaging Investigation of Dual-targeted C
Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ultrasound contrast agent targeting gelatin on uptake of mouse ascites hepatocellular carcinoma cell lines with high lymphatic metastasis].
He Y; Yang L; Yuan JJ; Zhu HH; Shao LY
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):319-324. PubMed ID: 32375448
[No Abstract] [Full Text] [Related]
16. Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy.
Zheng Y; Zhang Y; Ao M; Zhang P; Zhang H; Li P; Qing L; Wang Z; Ran H
J Microencapsul; 2012; 29(5):437-44. PubMed ID: 22299595
[TBL] [Abstract][Full Text] [Related]
17. Influence of nanostructure composition on its morphometric characterization by different techniques.
Carvalho Silva R; Alexandre Muehlmann L; Rodrigues Da Silva J; de Bentes Azevedo R; Madeira Lucci C
Microsc Res Tech; 2014 Sep; 77(9):691-6. PubMed ID: 24919585
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.
Wheatley MA; Forsberg F; Oum K; Ro R; El-Sherif D
Ultrasonics; 2006 Nov; 44(4):360-7. PubMed ID: 16730047
[TBL] [Abstract][Full Text] [Related]
19. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
